ET
Enlaza Therapeutics, Inc.
SEC filingPharmaceuticals · LA Jolla, CA
Amount raised$15Msold at filing
Total offering$15M
Investors in the raise1count reported to the SEC
FiledSep 11, 2025first sale Aug 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Marcos MillaDirector
Stephen SquintoDirector
Tighe ReardonExecutive Officer
Jay LichterDirector
Shelley ChuDirector
Sergio DuronExecutive Officer, Director
James TopperDirector
Sanford MadiganExecutive Officer
Executive officers, directors and promoters as listed on the Form D.